Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2007-01-26 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: AGEN (47000), Lot-et-Garonne
GRANDE PHARMACIE D'AGEN : revenue, balance sheet and financial ratios
GRANDE PHARMACIE D'AGEN is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in AGEN (47000),
this company of category PME
shows in 2023 a revenue of 2.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - GRANDE PHARMACIE D'AGEN (SIREN 494014236)
Indicator
2025
2024
2023
2022
2021
2019
2018
2017
2016
Revenue
N/C
N/C
2 763 807 €
N/C
N/C
N/C
N/C
3 382 208 €
3 316 750 €
Net income
191 851 €
203 206 €
254 924 €
367 408 €
252 826 €
329 762 €
304 210 €
306 236 €
327 157 €
EBITDA
N/C
N/C
338 540 €
N/C
N/C
N/C
N/C
443 517 €
477 135 €
Net margin
N/C
N/C
9.2%
N/C
N/C
N/C
N/C
9.1%
9.9%
Revenue and income statement
In 2025, GRANDE PHARMACIE D'AGEN generates positive net income of 192 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 327 k€ -> 192 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
191 851 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 6%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 86%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
6.262%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
86.124%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution GRANDE PHARMACIE D'AGEN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2021
2022
2023
2024
2025
Debt ratio
14.044
3.002
2.425
5.31
4.066
4.128
2.863
2.926
6.262
Financial autonomy
81.305
89.152
88.282
86.345
89.708
90.141
91.373
89.679
86.124
Repayment capacity
1.278
0.293
None
None
None
None
0.34
None
None
Cash flow / Revenue
10.033%
9.176%
None%
None%
None%
None%
9.323%
None%
None%
Sector positioning
Debt ratio
6.262025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Excellent
In 2025, the debt ratio of GRANDE PHARMACIE D'AGEN (6.26) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
86.12%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Excellent+11 pts over 3 years
In 2025, the financial autonomy of GRANDE PHARMACIE D'AGEN (86.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.34 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Excellent
In 2023, the repayment capacity of GRANDE PHARMACIE D'AGEN (0.34) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 279.70. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
279.702
Liquidity indicators evolution GRANDE PHARMACIE D'AGEN
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2021
2022
2023
2024
2025
Liquidity ratio
385.572
259.936
234.722
279.127
317.217
382.444
333.552
267.801
279.702
Interest coverage
0.0
0.0
None
None
None
None
0.0
None
None
Sector positioning
Liquidity ratio
279.72025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Excellent
In 2025, the liquidity ratio of GRANDE PHARMACIE D'AGEN (279.70) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.0x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of GRANDE PHARMACIE D'AGEN (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution GRANDE PHARMACIE D'AGEN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2021
2022
2023
2024
2025
Operating WCR
385 440 €
417 804 €
0 €
0 €
0 €
0 €
502 958 €
0 €
0 €
Inventory turnover (days)
45
42
0
0
0
0
49
0
0
Customer payment term (days)
4
4
0
0
0
0
6
0
0
Supplier payment term (days)
24
23
0
0
0
0
25
0
0
Positioning of GRANDE PHARMACIE D'AGEN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of GRANDE PHARMACIE D'AGEN is estimated at
3 047 575 €
(range 2 068 099€ - 4 782 066€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2068k€3047k€4782k€
3 047 575 €Range: 2 068 099€ - 4 782 066€
NAF 5 année 2025
Valuation method used
Net Income Multiple
191 851 €
×
15.9x
=3 047 576 €
Range: 2 068 099€ - 4 782 066€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare GRANDE PHARMACIE D'AGEN with other companies in the same sector:
Frequently asked questions about GRANDE PHARMACIE D'AGEN
What is the revenue of GRANDE PHARMACIE D'AGEN ?
The revenue of GRANDE PHARMACIE D'AGEN in 2023 is 2.8 M€.
Is GRANDE PHARMACIE D'AGEN profitable?
Yes, GRANDE PHARMACIE D'AGEN generated a net profit of 192 k€ in 2025.
Where is the headquarters of GRANDE PHARMACIE D'AGEN ?
The headquarters of GRANDE PHARMACIE D'AGEN is located in AGEN (47000), in the department Lot-et-Garonne.
Where to find the tax return of GRANDE PHARMACIE D'AGEN ?
The tax return of GRANDE PHARMACIE D'AGEN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does GRANDE PHARMACIE D'AGEN operate?
GRANDE PHARMACIE D'AGEN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart